Marina Chan

932 total citations
16 papers, 534 citations indexed

About

Marina Chan is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Marina Chan has authored 16 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 4 papers in Cell Biology. Recurrent topics in Marina Chan's work include Wnt/β-catenin signaling in development and cancer (4 papers), Cancer Cells and Metastasis (3 papers) and Computational Drug Discovery Methods (2 papers). Marina Chan is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (4 papers), Cancer Cells and Metastasis (3 papers) and Computational Drug Discovery Methods (2 papers). Marina Chan collaborates with scholars based in United States, South Africa and Germany. Marina Chan's co-authors include Taranjit S. Gujral, Gavin MacBeath, Peter K. Sorger, Leonid Peshkin, Marc W. Kirschner, Raymond S. Yeung, Heidi L. Kenerson, Eric C. Holland, Ramya Sivakumar and Nao Nishida‐Aoki and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Genes & Development.

In The Last Decade

Marina Chan

13 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marina Chan United States	10	331	200	86	77	56	16	534
Shane W. O’Brien United States	12	401 1.2×	188 0.9×	88 1.0×	88 1.1×	34 0.6×	14	602
Kristopher A. Lofgren United States	9	278 0.8×	198 1.0×	52 0.6×	88 1.1×	77 1.4×	20	451
Brunella Costanza Belgium	8	279 0.8×	197 1.0×	63 0.7×	156 2.0×	56 1.0×	9	470
Ignazia Tusa Italy	14	336 1.0×	117 0.6×	50 0.6×	114 1.5×	34 0.6×	30	597
Hengbo Zhou United States	12	357 1.1×	268 1.3×	74 0.9×	154 2.0×	75 1.3×	18	617
Brigitte Bisarò Italy	12	307 0.9×	172 0.9×	109 1.3×	103 1.3×	35 0.6×	16	513
Timothy A. Yap United Kingdom	8	289 0.9×	200 1.0×	63 0.7×	111 1.4×	71 1.3×	10	568
Kateřina Bouchalová Czechia	12	193 0.6×	229 1.1×	49 0.6×	128 1.7×	62 1.1×	35	486
Jarrod R. Tremayne United States	8	310 0.9×	264 1.3×	60 0.7×	75 1.0×	60 1.1×	13	491
Laura Bazley United Kingdom	3	253 0.8×	254 1.3×	73 0.8×	78 1.0×	65 1.2×	4	436

Countries citing papers authored by Marina Chan

Since Specialization

Citations

This map shows the geographic impact of Marina Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Chan more than expected).

Fields of papers citing papers by Marina Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Chan. The network helps show where Marina Chan may publish in the future.

Co-authorship network of co-authors of Marina Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Chan. A scholar is included among the top collaborators of Marina Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Chan. Marina Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Chan, Marina, et al.. (2026). A systems approach identifies MERTK as a therapeutic vulnerability in ZFTA-RELA-driven ependymomas. Proceedings of the National Academy of Sciences. 123(7). e2514518123–e2514518123.

Chan, Marina, Manabu Nukaya, Sean M. Ronnekleiv‐Kelly, et al.. (2025). DNAJ-PKAc fusion heightens PLK1 inhibitor sensitivity in fibrolamellar carcinoma. Gut. 74(10). 1680–1693. 1 indexed citations

Nishida‐Aoki, Nao, Marina Chan, Yuqi Kang, et al.. (2025). Drug screening in 3D microtumors reveals DDR1/2-MAPK12-GLI1 as a vulnerability in cancer-associated fibroblasts. Cell Reports Medicine. 6(10). 102357–102357.

Long, Donald, Marina Chan, K. Rosanna, et al.. (2024). Proteo-metabolomics and patient tumor slice experiments point to amino acid centrality for rewired mitochondria in fibrolamellar carcinoma. Cell Reports Medicine. 5(9). 101699–101699. 1 indexed citations

Chan, Marina, et al.. (2024). A kinase to cytokine explorer to identify molecular regulators and potential therapeutic opportunities. eLife. 12. 2 indexed citations

Chan, Marina, et al.. (2023). A kinase to cytokine explorer to identify molecular regulators and potential therapeutic opportunities. eLife. 12.

Bello, Thomas R., Marina Chan, Martin Golkowski, et al.. (2021). KiRNet: Kinase-centered network propagation of pharmacological screen results. Cell Reports Methods. 1(2). 100007–100007. 10 indexed citations

Chan, Marina, et al.. (2021). Machine learning identifies molecular regulators and therapeutics for targeting SARS‐CoV2‐induced cytokine release. Molecular Systems Biology. 17(9). e10426–e10426. 19 indexed citations

Golkowski, Martin, Ho-Tak Lau, Marina Chan, et al.. (2020). Pharmacoproteomics Identifies Kinase Pathways that Drive the Epithelial-Mesenchymal Transition and Drug Resistance in Hepatocellular Carcinoma. Cell Systems. 11(2). 196–207.e7. 25 indexed citations

10.

Szulzewsky, Frank, Sonali Arora, Pia Hoellerbauer, et al.. (2020). Comparison of tumor-associated YAP1 fusions identifies a recurrent set of functions critical for oncogenesis. Genes & Development. 34(15-16). 1051–1064. 58 indexed citations

11.

Xue, Andrew G., Marina Chan, & Taranjit S. Gujral. (2020). Pan-cancer analysis of the developmental pathways reveals non-canonical wnt signaling as a driver of mesenchymal-type tumors. Translational research. 224. 1–15. 10 indexed citations

12.

Sivakumar, Ramya, Marina Chan, Nao Nishida‐Aoki, et al.. (2019). Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery. OncoImmunology. 8(12). e1670019–e1670019. 65 indexed citations

13.

Gujral, Taranjit S., Marina Chan, Leonid Peshkin, et al.. (2014). A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis. Cell. 159(4). 844–856. 271 indexed citations

14.

Gujral, Taranjit S., et al.. (2013). Family-wide Investigation of PDZ Domain-Mediated Protein-Protein Interactions Implicates β-Catenin in Maintaining the Integrity of Tight Junctions. Chemistry & Biology. 20(6). 816–827. 27 indexed citations

15.

Gujral, Taranjit S., Marina Chan, Mark Sevecka, et al.. (2012). A Dual Array-Based Approach to Assess the Abundance and Posttranslational Modification State of Signaling Proteins. Science Signaling. 5(206). pl1–pl1. 21 indexed citations

16.

Potter, Gregory D., Michael C. Baird, Marina Chan, & Susan P.C. Cole. (2006). Cellular toxicities of new titanocene dichloride derivatives containing pendant cyclic alkylammonium groups. Inorganic Chemistry Communications. 9(11). 1114–1116. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact